Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andreas Hadjimichael currently holds 3,856,597 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andreas Hadjimichael has been a net seller of KPTI stock. They have purchased $5.0M and sold $24.8M worth of shares.
Andreas Hadjimichael's most recent insider trade was on Nov 17, 2022, when they sold 3,445,940 shares at $0.00 per share.
Andreas Hadjimichael serves as Executive at Karyopharm Therapeutics Inc. (KPTI). They have executed 25 insider transactions totaling $29.8M over their tenure at the company.
Andreas Hadjimichael holds the position of Executive at Karyopharm Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Andreas Hadjimichael has shown a selling trading pattern, with $5.0M in total purchases and $24.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andreas Hadjimichael was on Nov 17, 2022, when they purchased $5.0M worth of ACRV shares. This transaction involved 400,000 shares at $12.50 per share.
Andreas Hadjimichael currently owns 3,856,597 shares of Karyopharm Therapeutics Inc. (KPTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andreas Hadjimichael's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andreas Hadjimichael has 25 Form 4 filings on record as an insider at Karyopharm Therapeutics Inc..
Set alerts for Andreas Hadjimichael and 40,000+ other insiders.